Related Experiment Videos
Carboplatin and vinorelbine in advanced non-small-cell lung cancer
P Pronzato1, E Ghio, P L Losardo
1Oncologia Medica, Ospedale S. Andrea, Loc Felettino, La Spezia, Italy.
Cancer Chemotherapy and Pharmacology
|January 1, 1996
Abstract:
A total of 32 patients with advanced non-small-cell lung cancer were treated with carboplatin (350 mg/m2, day 1) and vinorelbine (days 1 and 8) every 28 days. A response rate of 28% (95% confidence limits 12.5 - 43.7%) was observed. The activity of this combination was demonstrated in an outpatient setting with acceptable toxicity.